Racial and Ethnic Disparities in Early-Onset Colorectal Cancer Survival
Clinical Gastroenterology and Hepatology · 2023-02 · 21 (2) · 497-506.e3
DOI: 10.1016/j.cgh.2022.05.035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023-02. Verfasst von Timothy A Zaki und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas. Hauptthemen laut MEDLINE: White People, Colorectal Neoplasms. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Young adults diagnosed with colorectal cancer (CRC) comprise a growing, yet understudied, patient population. We estimated 5-year relative survival of early-onset CRC and examined disparities in survival by race-ethnicity in a population-based sample. METHODS: We used the National Cancer Institute's Surveillance, Epidemiology, and End Results program of cancer registries to identify patients diagnosed with early-onset CRC (20-49 years of age) between January 1, 1992, and December 31, 2013. For each racial-ethnic group, we estimated 5-year relative survival, overall and by sex, tumor site, and stage at diagnosis. To illustrate temporal trends, we compared 5-year relative survival in 1992-2002 vs 2003-2013. We also used Cox proportional hazards regression models to examine the association of race-ethnicity and all-cause mortality, adjusting for age at diagnosis, sex, county type (urban vs rural), county-level median household income, tumor site, and stage at diagnosis. RESULTS: We identified 33,777 patients diagnosed with early-onset CRC (58.5% White, 14.0% Black, 13.0% Asian, 14.5% Hispanic). Five-year relative survival ranged from 57.6% (Black patients) to 69.1% (White patients). Relative survival improved from 1992-2002 to 2003-2013 for White patients only; there was no improvement for Black, Asian, or Hispanic patients. This pattern was similar by sex, tumor site, and stage at diagnosis. In adjusted analysis, Black (adjusted hazard ratio [aHR], 1.42; 95% confidence interval [CI], 1.36-1.49), Asian (aHR, 1.06; 95% CI, 1.01-1.12), and Hispanic (aHR, 1.16; 95% CI, 1.10-1.21) race-ethnicity were associated with all-cause mortality. CONCLUSION: Our study adds to the well-documented disparities in CRC in older adults by demonstrating persistent racial-ethnic disparities in relative survival and all-cause mortality in patients with early-onset CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
- Department of Medicine, New York University Langone Health, New York, New York; Department of Medicine, VA New York Harbor Health Care System, New York, New York.
- Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.
- Department of Health Promotion and Behavioral Sciences, School of Public Health, University of Texas Health Science Center at Houston, Houston, Texas. Electronic address: caitlin.c.murphy@uth.tmc.edu.
Förderung
- NCI NIH HHS
Zitieren
APA
Zaki, T. A., Liang, P. S., May, F. P., & Murphy, C. C. (2023). Racial and Ethnic Disparities in Early-Onset Colorectal Cancer Survival. Clinical Gastroenterology and Hepatology, 21(2), 497-506.e3. https://doi.org/10.1016/j.cgh.2022.05.035
Vancouver
Zaki TA, Liang PS, May FP, Murphy CC. Racial and Ethnic Disparities in Early-Onset Colorectal Cancer Survival. Clinical Gastroenterology and Hepatology. 2023;21(2):497-506.e3. doi:10.1016/j.cgh.2022.05.035
BibTeX
@article{Zaki2023,
author = {Zaki, Timothy A and Liang, Peter S and May, Folasade P and Murphy, Caitlin C},
title = {Racial and Ethnic Disparities in Early-Onset Colorectal Cancer Survival},
journal = {Clinical Gastroenterology and Hepatology},
year = {2023},
volume = {21},
number = {2},
pages = {497--506.e3},
doi = {10.1016/j.cgh.2022.05.035}
}
EUVIMED